Sarepta Therapeutics, Inc. (SRPT) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
markkabbash markkabbash 10/27/2014 1 week $23.56 $16.17 -31.37% 31 Ended
Netteligent Netteligent 10/03/2014 1 month $23.30 $16.17 -30.6% 30 Ended
Vozniak Vozniak 01/21/2014 1 week $26.78 $24.21 -9.6% -9 Ended
Strina Strina 01/04/2013 1 week $27.90 $26.19 -6.13% -6 Ended
JOKER66 JOKER66 12/10/2012 1 week $25.32 $25.26 -0.24% -1 Ended
Rich76 Rich76 11/15/2012 1 month $25.28 $25.26 -0.08% -1 Ended
Comments: Strong Buy near term
Minutemen Minutemen 10/01/2012 3 months $16.28 $23.79 +46.13% 46 Ended
Comments: Unprecented positive phase IIb data in treatment of Duchenne Muscular Dystrophy.
nana nana 09/13/2012 1 day $14.05 $13.93 -0.85% -1 Ended
inBestment inBestment 07/24/2012 3 months $8.52 $24.41 +186.5% 186 Ended
Comments: Industry sector growing or poised for growth
Eventus Eventus 05/25/2012 1 month $0.73 $0.64 -12.33% 12 Ended
Comments: Projecting declines beyond the short-term
lakesideguy lakesideguy 04/12/2010 3 months N/A Ended
Comments: AVII has typically weathered bad financial storms. Although management change is occuring at the top end at this price this a good bargain for the long. It can go anywhere but up from here!
Aleixo Aleixo 12/04/2009 3 months N/A Ended

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.